Skip to main content

Equitas Small Finance Bank to raise ₹1,750 crore capital following 406% surge in Q4 profit

Equitas SFB's board has approved a ₹1,750 crore capital infusion plan, comprising ₹1,250 crore through equity and ₹500 crore through debt, coming on the heels of a record quarterly performance.

Author Image
Sahi Markets
Published: 24 Jun 2026, 01:06 PM IST (2 weeks ago)
Last Updated: 24 Jun 2026, 01:06 PM IST (2 weeks ago)
3 min read
Reviewed by Arpit Seth

Market snapshot: Equitas Small Finance Bank (EQUITASBNK) has received board approval to raise a total of ₹1,750 crore in fresh capital. This involves a ₹1,250 crore Qualified Institutions Placement (QIP) and ₹500 crore via debt securities. The decision underscores the bank’s intent to bolster its capital base to support its aggressive 20%+ credit growth targets for the upcoming fiscal years.

Data Snapshot

  • Total capital infusion: ₹1,750 crore
  • Equity via QIP: ₹1,250 crore
  • Debt via NCDs/Bonds: ₹500 crore
  • Market Capitalisation: ₹8,900 crore
  • Q4 FY26 Net Profit: ₹213 crore (up 406% YoY)

What's Changed

  • Equitas SFB is shifting from a conservation phase to an expansionary capital phase following its turnaround in asset quality.
  • The total fundraise represents nearly 20% of the bank's current market capitalisation, signaling a massive liquidity buffer.
  • Fresh capital will likely lower the cost of funds and improve the Tier-I capital adequacy ratio beyond the current 16.68%.

Key Takeaways

  • Strategic growth pivot: Capital will fund a 20%+ advance growth target for FY27.
  • De-risking microfinance: Management is steering the book toward secured assets (affordable housing, gold loans) which currently comprise 90% of advances.
  • Institutional confidence: QIP route suggests strong institutional demand for the bank’s diversifying loan book.

SAHI Perspective

Equitas SFB's capital raise is a proactive move to front-load growth capital before the universal banking license application. By raising ₹1,750 crore now, the bank secures its balance sheet against potential volatility while ensuring it has the 'ammunition' to capture market share in high-yield segments like affordable housing and used vehicle finance.

Market Implications

The capital raise is expected to be EPS-dilutive in the near term but ROE-accretive in the medium term as the bank deploys funds into high-yielding secured loans. For the sector, it highlights a trend among Small Finance Banks (SFBs) to aggressively tap capital markets to meet regulatory net worth requirements for universal bank transitions.

Trading Signals

Market Bias: Bullish

Record Q4 PAT of ₹213 crore and a planned ₹1,750 crore infusion signal a strong growth trajectory. The CRAR of 20.31% and GNPA reduction to 2.60% provide a high margin of safety.

Overweight: Small Finance Banks, Secured Retail Lending, Affordable Housing Finance

Underweight: Unsecured Microfinance

Trigger Factors:

  • QIP pricing announcement
  • Final RBI approval for Universal Banking transition
  • Sustainability of NIM at 7% level

Time Horizon: Medium-term (3-12 months)

Industry Context

The SFB industry is currently undergoing a structural shift toward 'Secured-First' portfolios. Equitas is leading this trend by capping microfinance exposure at 10% and scaling non-MFI books by 21% YoY. Competitors like AU SFB and Ujjivan are similarly diversifying, but Equitas's rapid 406% PAT recovery puts it in a unique position for capital deployment.

Key Risks to Watch

  • Equity dilution impact on near-term EPS.
  • Sensitivity of NIMs to rising deposit competition.
  • Geographic concentration in Tamil Nadu (44% of advances).

Recent Developments

In April 2026, Equitas SFB reported its highest-ever quarterly PAT of ₹213 crore, fueled by a 22% growth in advances. The RBI also approved the re-appointment of PN Vasudevan as MD & CEO, ensuring leadership continuity for the next growth cycle.

Closing Insight

Equitas SFB is evolving from a microfinance-heavy lender into a diversified retail bank. The ₹1,750 crore capital boost is the final piece of the puzzle required to drive its FY27 roadmap of 20% advance growth and an ROA of 1.5%.

FAQs

Why is Equitas SFB raising ₹1,750 crore despite having a 20.31% capital adequacy ratio?

While the current CRAR is healthy, the bank targets aggressive 20%+ advance growth in FY27. This capital ensures they stay ahead of regulatory requirements and maintain buffers while pivoting toward higher-growth secured segments.

How will the ₹1,250 crore QIP impact existing retail shareholders?

A QIP typically involves issuing new shares to institutional investors, which leads to equity dilution for existing shareholders. However, if the funds are deployed effectively into high-yield loans, the long-term ROE and stock valuation often improve.

What does this fundraise signal about the bank's Universal Banking ambitions?

Strengthening the capital base is a critical prerequisite for the RBI's universal banking license. This ₹1,750 crore raise, combined with the bank's diversified loan book (90% secured), creates a strong case for regulatory approval in the coming quarters.

High Performance Trading with SAHI.

All topics